A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia

Full Title

A Phase II Trial of Obecabtagene Autoleucel Consolidation in Adult Patients with Acute Lymphoblastic Leukemia in First Complete Remission Without Measurable Residual Disease

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description. 

Contact

For more information or to see if you can join this study, please call Dr. Jae Park’s office at 646-608-3743. 

Protocol

25-342

Phase

Phase II (phase 2)

Investigator

Jae Park

Co-Investigators

Mark B. Geyer

Diseases

Leukemia › Acute Lymphoblastic Leukemia

Locations

Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau

ClinicalTrials.gov ID

NCT07400029

ClinicalTrials.gov

Visit ClinicalTrials.gov for full clinical trial description